All News

Gallup has released the results of its annual survey about which professions Americans deem the most honest and maintain the highest ethical standards. Once again pharmacists are highly rated, finishing second on the list.

Tresiba is now indicated to treat patients with diabetes as young as 1-year-old.

Some diabetes drugs are thought to cause weight loss through the hypothalamus, but other parts of the brain may be involved.

This legislation has introduced several new requirements for pharmacies, and many pharmacists are wondering what steps can be taken to implement the requirements contained within.

After 2 years of exclusion, Harvoni has been added to the Express Scripts national formulary for the treatment of hepatitis C.

The state’s health department recommends that patients be screened for HIV, and hepatitis B and C viruses.

Patients with diabetes buying Eli Lilly insulin can potentially save 40% off retail price.

Cyclin-dependent kinase inhibitor reduces Ki67 expression and shows promise in breast cancer treatment.

Agreement will expand treatment options for patients with hepatitis C.

Up to 24% of patients with irritable bowel syndrome with constipation responded to treatment.

HIV infection continues to rise in across European countries.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

When treatment with DMARDs does not work, biologic agents are used to treat RA.

Lack of adherence to HIV medications can create resistance since the virus mutates quickly.

Risankizumab achieved higher rates of clinical response in patients with Crohn’s disease.

Pennsylvania health department recommends that patients be screened for HIV, and hepatitis B and C viruses.

Risankizumab is also being evaluated for the treatment of psoriasis, psoriatic arthritis, and asthma.

A sharp rise in opioid-related complications among newborns in rural communities highlights the severity of the opioid epidemic in these areas.

Drug candidate can treat individuals who have PTSD associated with their military service.

Rubraca is the latest targeted agent that treats cancers caused by specific mutations in a patient’s gene.

The FDA has granted orphan drug designation to AbbVie for risankizumab (ABBV-066) for the treatment of Crohn’s disease in pediatric patients.

As the year comes to an end, pharmacy students may be looking forward to a much needed semester break.

It’s that time of the year again where we all feed our faces and start to dread stepping back on the scale. You want to lose the weight but you just can’t stop eating. You keep telling yourself you will start your diet Monday or after the holidays. Not only is all of the food you’re ingesting adding numbers to the scale, but it’s also putting you at an increased risk of developing diseases such as congestive heart disease, hypertension, stroke, type 2 diabetes, and various cancers. Here is some information that may help you keep the weight off and start shedding some pounds.

Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, clinical trial.

Officials with Mylan have announced the launch of generic EpiPen (epinephrine injection, USP) Auto-Injector at half the cost of its brand name counterpart.

In a letter to the new power structure in Washington, D.C., the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), and the National Alliance of State Pharmacy Associations (NASPA) have detailed steps necessary to leverage pharmacy patient care and prevent higher costs that result from untreated conditions.

FDA grants accelerated approval for rucaparib (Rubraca) to treat advanced ovarian cancer.

Officials with Clovis Oncology announced today they have received accelerated FDA approval for Rubraca (rucaparib) to treat advanced ovarian cancers in women.